Today's Date
Carfilzomib and Belatacept for Desensitization
(
ADAPT
)
ITN Protocol #:
ITN089ST
Branded Name:
ADAPT
ClinicalTrials.Gov ID:
NCT05017545Treatment Protocol #:
Therapeutic Area:
Transplantation
Current Status:
Enrollment
Summary:
Measuring the Impact of Carfilzomib and Belatacept on Allogeneic Desensitization in Prospective Kidney Transplant Recipients
Clinical Operations Associate Director
Clinical Operations Manager
ITN Biologist
ITN Biostat
ITN Clinical Trial Physician
NIAID Regulator Officer
Rho Data Manager
Rho Scientist
PPD Lead Monitor
Study Personnel:
